Page 674 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 674

CHaPTEr 47  Allergic Disorders of the Eye            647


           10.  Bacon AS, Ahluwalia P, Irani AM, et al. Tear and conjunctival changes   19.  Abu El-Asrar AM, Struyf S, Al-Kharashi SA, et al. Chemokines in the
             during the allergen-induced early- and late-phase responses. J Allergy   limbal form of vernal keratoconjunctivitis. Br J Ophthalmol
             Clin Immunol 2000;106(5):948–54.                       2000;84(12):1360–6.
           11.  Magone MT, Whitcup SM, Fukushima A, et al. The role of    20.  Vichyanond P, Pacharn P, Pleyer U, et al. Vernal keratoconjunctivitis: a
             IL-12 in the induction of late-phase cellular infiltration in a    severe allergic eye disease with remodeling changes. Pediatr Allergy
             murine model of allergic conjunctivitis. J Allergy Clin Immunol   Immunol 2014;25(4):314–22.
             2000;105(2 Pt 1):299–308.                            21.  Dale SB, Saban DR. Linking immune responses with fibrosis in allergic
           12.  Stern ME, Siemasko K, Gao J, et al. Role of interferon-gamma in a mouse   eye disease. Curr Opin Allergy Clin Immunol 2015;15(5):467–75.
             model of allergic conjunctivitis. Invest Ophthalmol Vis Sci   22.  Gonzalez-Lopez JJ, Lopez-Alcalde J, Morcillo Laiz R, et al. Topical
             2005;46(9):3239–46.                                    cyclosporine for atopic keratoconjunctivitis. Cochrane Database Syst Rev
           13.  Zheng X, Ma P, de Paiva CS, et al. TSLP and downstream molecules in   2012;(9):CD009078.
             experimental mouse allergic conjunctivitis. Invest Ophthalmol Vis Sci   23.  Fukushima A, Ozaki A, Jian Z, et al. Dissection of antigen-specific
             2010;51(6):3076–82.                                    humoral and cellular immune responses for the development of
           14.  Metz DP, Bacon AS, Holgate S, et al. Phenotypic characterization of T   experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.
             cells infiltrating the conjunctiva in chronic allergic eye disease. J Allergy   Curr Eye Res 2005;30(4):241–8.
             Clin Immunol 1996;98(3):686–96.                      24.  Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology
           15.  Saban DR. The chemokine receptor CCR7 expressed by dendritic cells: a   1990;97(8):992–1000.
             key player in corneal and ocular surface inflammation. Ocul Surf   25.  Schlereth S, Lee HS, Khandelwal P, et al. Blocking CCR7 at the ocular
             2014;12(2):87–99.                                      surface impairs the pathogenic contribution of dendritic cells in allergic
           16.  Metz DP, Hingorani M, Calder VL, et al. T-cell cytokines in chronic   conjunctivitis. Am J Pathol 2012;180(6):2351–60.
             allergic eye disease. J Allergy Clin Immunol 1997;100(6 Pt 1):817–24.  26.  Erdinest N, Solomon A. Topical immunomodulators in the management
           17.  Reyes NJ, Saban DR. T helper subsets in allergic eye disease. Curr Opin   of allergic eye diseases. Curr Opin Allergy Clin Immunol
             Allergy Clin Immunol 2014;14(5):477–84.                2014;14(5):457–63.
           18.  Leonardi A, Curnow SJ, Zhan H, et al. Multiple cytokines in human tear
             specimens in seasonal and chronic allergic eye disease and in conjunctival
             fibroblast cultures. Clin Exp Allergy 2006;36(6):777–84.
   669   670   671   672   673   674   675   676   677   678   679